FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for dextroamphetamine sulfate from Prasco Laboratories under ANDA 040776, marking an approved modification to the generi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• Dextroamphetamine sulfate (dextroamphetamine sulfate)

Snippet

SUPPL AP for DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)